Equillium, Inc. (EQ)
2.21
-0.01
(-0.45%)
USD |
NASDAQ |
Sep 04, 16:00
2.21
0.00 (0.00%)
After-Hours: 20:00
Equillium Research and Development Expense (Quarterly) : 2.749M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.749M |
| March 31, 2026 | 2.991M |
| December 31, 2025 | 1.536M |
| September 30, 2025 | 1.301M |
| June 30, 2025 | 4.083M |
| March 31, 2025 | 5.924M |
| December 31, 2024 | 7.315M |
| September 30, 2024 | 9.562M |
| June 30, 2024 | 10.81M |
| March 31, 2024 | 9.743M |
| December 31, 2023 | 9.183M |
| September 30, 2023 | 8.974M |
| June 30, 2023 | 9.61M |
| March 31, 2023 | 9.272M |
| December 31, 2022 | 8.525M |
| September 30, 2022 | 8.771M |
| June 30, 2022 | 9.488M |
| Date | Value |
|---|---|
| March 31, 2022 | 33.81M |
| December 31, 2021 | 7.549M |
| September 30, 2021 | 6.965M |
| June 30, 2021 | 5.985M |
| March 31, 2021 | 5.88M |
| December 31, 2020 | 6.567M |
| September 30, 2020 | 4.218M |
| June 30, 2020 | 3.893M |
| March 31, 2020 | 4.706M |
| December 31, 2019 | 5.449M |
| September 30, 2019 | 4.182M |
| June 30, 2019 | 4.25M |
| March 31, 2019 | 3.759M |
| December 31, 2018 | 2.518M |
| September 30, 2018 | 1.222M |
| March 31, 2018 | 0.663M |
| September 30, 2017 | 0.0499M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 21.96M |
| Fortress Biotech, Inc. | 0.805M |
| Cue Biopharma, Inc. | 48.98M |
| Legend Biotech Corp. | 96.16M |
| Dianthus Therapeutics, Inc. | 48.69M |